You just read:

Deal Announced Today Between Celgene Corporation and Epizyme, an LLS-partner, Will Help Advance a Therapy for Patients with Mixed Lineage Leukemia

News provided by

The Leukemia & Lymphoma Society

Apr 26, 2012, 12:22 ET